Cited in:


This article has been cited by:

  1. 1
    Hans-Joachim Helms, Norbert Benda, Jörg Zinserling, Thomas Kneib, Tim Friede, Spline-based procedures for dose-finding studies with active control, Statistics in Medicine, 2015, 34, 2
  2. 2
    P. Brain, S. Kirby, R. Larionov, Fitting Emax models to clinical trial dose–response data when the high dose asymptote is ill defined, Pharmaceutical Statistics, 2014, 13, 6
  3. 3
    H.-J. Helms, N. Benda, T. Friede, Point and interval estimators of the target dose in clinical dose-finding studies with active control, Journal of Biopharmaceutical Statistics, 2014, 150527104153001


  4. 4
    E. Ducourau, D. Ternant, T. Lequerre, P. Fuzibet, X. Le Loet, H. Watier, P. Goupille, G. Paintaud, O. Vittecoq, D. Mulleman, Towards an individualised target concentration of adalimumab in rheumatoid arthritis, Annals of the Rheumatic Diseases, 2014, 73, 7, 1428


  5. 5
    Oliver N. Keene, Phase II Trials,